High Recurrence Rates of Basal Cell Carcinoma After Mohs Surgery in Patients With Chronic Lymphocytic Leukemia
Open Access
- 1 August 2004
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 140 (8) , 985-988
- https://doi.org/10.1001/archderm.140.8.985
Abstract
The aggressive nature of nonmelanoma skin cancer in patients with chronic lymphocytic leukemia (CLL), as evidenced by significantly greater subclinical tumor extension, makes Mohs micrographic surgery an optimal technique for management.1-3 Use of micrographic surgery routinely results in the highest cure rates, concomitantly maximizing the preservation of normal adjacent tissue to simplify reconstruction of the defect.3-5Keywords
This publication has 14 references indexed in Scilit:
- The Management of Melanoma and Nonmelanoma Skin Cancer: A Review for the Primary Care PhysicianMayo Clinic Proceedings, 2001
- Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry dataCancer, 2001
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 1995
- Rapid Cytokeratin Stains Enhance the Sensitivity of Mohs Micrographic Surgery for Squamous Cell CarcinomaThe Journal of Dermatologic Surgery and Oncology, 1994
- Clinicopathologic features of cutaneous squamous cell carcinomas of the head and neck in patients with chronic lymphocytic leukemia/small lymphocytic lymphomaHuman Pathology, 1988
- Squamous cell carcinoma of head and neck in patients with well-differentiated lymphocytic lymphomaCancer, 1987
- Mohs surgery: Techniques, indications, and applications in head and neck surgeryHead & Neck Surgery, 1983
- Mohs surgery. Technique, indications, applications, and the futureArchives of Dermatology, 1983
- The value of typing basal cell carcinomas in predicting recurrence after surgical excisionBritish Journal of Dermatology, 1977